Researchers pioneer a novel treatment for the most common autoimmune encephalitis

Researchers at DZNE and Charité – Universitätsmedizin Berlin have pioneered a novel treatment for the most common autoimmune encephalitis.

Will Geron be acquired? The long-short view

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their

June 13, 2024

Vivid Health Expands GenAI Platform to Support Home Health Market

What You Should Know: – Vivid Health, an AI-powered care management company, today announced it’s expanding its generative AI platform to support the home health market.

August 13, 2024

Hospitals struggle to make money on CAR-T cancer therapies, but their fortunes may change

WASHINGTON — Hospitals for years have complained that Medicare pays so little for CAR-T cancer treatments that they sometimes lose money administering the incredibly expensive

July 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.